We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioLineRx Announces Issuance of US Patent Covering Use of BL-8040 in Immunotherapy

News   Mar 15, 2014

 
BioLineRx Announces Issuance of US Patent Covering Use of BL-8040 in Immunotherapy
 
 
Advertisement
 

RELATED ARTICLES

Blood Test Could Track Immune Response to COVID-19

News

A highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19 reveals new aspects of how SARS-CoV-2 causes disease.

READ MORE

Platinum-based Chemo May Improve Survival in Certain Metastatic Pancreatic Cancer Patients

News

Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, compared with patients that did not have these mutations, according to a new study.

READ MORE

Two Biomarkers Help Predict Immunotherapy Response in Metastatic Breast Cancer

News

Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy treatment in metastatic breast cancer and may help to identify the patients most likely to benefit.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE